Sharps Compliance (SMED) Misses Q4 EPS by 4c, Revenues Miss

Sharps Compliance (NASDAQ: SMED) reported Q4 EPS of ($0.01), $0.04 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $9.9 million versus the consensus estimate of $11.25 million.

David P. Tusa, President and Chief Executive Officer of Sharps, stated, “While we were disappointed with fourth quarter customer billings in the Pharmaceutical Manufacturer and flu shot related businesses, we are very pleased with the fourth quarter growth of our unused medication and route-based pickup solutions, which experienced year-over-year increases in billings of 62% and 21%, respectively. In fact, these solutions contributed 37% of total billings for the quarter up from 25% in the prior year period reflecting the strategic transformation to expand our solution offerings to the small to medium quantity generator markets.”

For earnings history and earnings-related data on Sharps Compliance (SMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c